CAC
NUVB.WS

Cowen and Company’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Cowen and Company’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,277
Closed -$1.5K – 212
2024
Q3 		$1.5K Buy
15,277
+100
+0.7% +$18 ﹤0.01% 590
2024
Q2 		$2.43K Sell
15,177
-644
-4% -$132 ﹤0.01% 562
2024
Q1 		$4.79K Buy
+15,821
New +$1.88K ﹤0.01% 579
2021
Q3 		– Sell
-26,250
Closed -$68K – 667
2021
Q2 		$68K Sell
26,250
-20,304
-44% -$66.2K ﹤0.01% 374
2021
Q1 		$124K Buy
+46,554
New +$135K 0.01% 309

Other funds holding NUVB.WS

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
GCM
Greenland Capital Management New York $812M AUM 45.54% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Cowen and Company's NUVB.WS Position: Q4 2024 in Review

Cowen and Company sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q4 2024, closing a stake of 15,277 shares — an estimated $1.5K sold.

Cowen and Company first reported a position in NUVB.WS in Q1 2021 and held it in 5 quarters. The position peaked at $124K in Q1 2021. 23 funds tracked by Wall St. Rank hold NUVB.WS as of Q4 2024.

  • Cowen and Company reported no remaining Nuvation Bio Inc Warrants position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 15,277 Nuvation Bio Inc Warrants shares in Q4 2024, an estimated $1.5K.
  • Cowen and Company first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 5 quarters.
  • Cowen and Company's Nuvation Bio Inc Warrants position peaked at $124K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.